A multicenter, randomized, double-blind, placebo-controlled, parallel group study of the efficacy and safety of topiramate in the treatment of obese patients with mild to moderate essential hypertension.
Phase of Trial: Phase III
Latest Information Update: 30 Jun 2009
At a glance
- Drugs Topiramate (Primary)
- Indications Essential hypertension; Obesity
- Focus Registrational; Therapeutic Use
- 23 Jun 2009 Actual patient number (531) added as reported by ClinicalTrials.gov.
- 14 Nov 2005 New trial record.